Make the profile of
Clear Labs yours.

Company description

Clear Labs is a genomics technology company that delivers automated next-generation sequencing (NGS) platforms, data analytics, and actionable insights across infectious disease research, oncology research, and food safety testing. Founded by genomics scientists and software engineers, Clear Labs is committed to developing innovative solutions that contribute to pathogen surveillance, infectious disease management, and cancer genomics, serving clinical laboratories, food safety organizations, and research institutions.

Headquartered in San Carlos, California, Clear Labs has expanded its platform from environmental pathogen detection in the food industry to clinical and research applications including SARS-CoV-2 surveillance, wastewater monitoring, microbial identification, and oncology NGS automation. The company has secured $30 million in Series D financing from investors including Counterpoint Global (Morgan Stanley), Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures, Nimble Ventures, and Redmile, underscoring strong industry confidence in its technology roadmap.

Core Product Portfolio

• Clear Dx® – An automated genomic solutions platform originally developed for infectious disease applications and now expanding into oncology. The Clear Dx™ System supports end-to-end automated workflows and has been enhanced with additional capabilities including the Clear Dx™ Microbial ID tNGS assay workflow for next-day identification of bacterial and fungal pathogens from sterile site specimens.
• Clear Ix™ – The rebranded infectious disease research portfolio (formerly Clear Dx™ for infectious disease), offering whole genome sequencing (WGS) and targeted next-generation sequencing (tNGS) for infectious pathogens. This platform supports microbial surveillance, outbreak detection, and infection control research.
• Clear Safety™ – A food safety testing solution leveraging NGS for Listeria and Salmonella sequencing, designed to reinvent the way food is tested and analyzed before reaching consumers.

Key Capabilities and Technology

• Fully automated, end-to-end next-generation sequencing workflows that reduce manual intervention and accelerate time-to-result.
• Whole genome sequencing (WGS) platform that accelerates detection of infectious disease outbreaks and informs public health response and outbreak management.
• Targeted NGS (tNGS) capabilities for rapid bacterial and fungal detection from clinical specimens.
• Microbial Surveillance WGS solution for bacterial and fungal isolates, enabling comprehensive pathogen monitoring.
• Oncology-focused NGS automation, including a collaboration with Labcorp to develop streamlined, scalable, in-house genomic testing workflows.
• Integration of Pillar Biosciences' SLIMamp® chemistry into the Clear Dx™ platform, expanding automation technology into oncology applications, as showcased at the AMP Annual Meeting 2025.
• Software and data analytics tools that translate sequencing data into actionable insights for research and surveillance purposes.

Market Applications and Industry Recognition

• Clinical and public health laboratories seeking automated infectious disease surveillance and outbreak response tools.
• Oncology research organizations requiring scalable, automated genomic testing workflows.
• Food safety testing laboratories leveraging NGS to improve pathogen detection accuracy and throughput.
• Clear Labs' Co-founder and CEO, Sasan Amini, was recognized as one of the Top 50 Healthcare AI Entrepreneurs of 2025 by Great Entrepreneurs.
• The company has been highlighted among the most prominent health tech innovations by Health Tech World and featured in Genome Web for its push of automated whole-genome sequencing into the clinical market.
• All products are designated For Research Use Only (RUO) and are not intended for use in diagnostic procedures.

Clear Labs continues to evolve its platform to meet the changing needs of infectious disease and oncology research, combining genomics expertise with software engineering to deliver clarity and actionable intelligence that protects life across clinical, research, and food safety environments.

AI-generated · replace with your own

Software attributed to Clear Labs

• Clear DxView
• Clear IxView
• Clear SafetyView

Edit all with premium access